VTGN
VistaGen Therapeutics Inc
0.3684$
+46.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -581.0% | – | – | -4,717.7% | -1,108.2% | -4,081.2% | – | -2,426.0% | -8,661.9% | -5,235.3% | |
| – | – | 4.4% | – | – | 30.9% | 10.8% | 64.1% | – | 53.4% | 130.7% | 57.8% | |
| – | – | 68.1% | – | – | 1,144.0% | 211.7% | 313.9% | – | 205.1% | 887.9% | 315.0% | |
| – | – | 289.4% | – | – | 1,144.0% | 211.7% | 313.9% | – | – | – | – | |
| – | – | -54.4% | – | – | 48.0% | 315.5% | -173.0% | – | 74.5% | 979.4% | -73.9% | |
| – | – | 19.1% | – | – | 82.5% | 25.3% | 18.1% | – | 5.7% | 39.3% | 11.9% | |
| – | – | -19.1% | – | – | -82.5% | -25.3% | -18.1% | – | -5.7% | -2,705.3% | -69.1% | |
| – | – | 100,560.0% | – | – | 378,323.4% | 127,177.6% | 85,228.6% | – | – | – | – | |
| – | – | 100,560.0% | – | – | 378,323.4% | 127,177.6% | 85,228.6% | – | – | – | – | |
| – | – | -14.7% | – | – | -88.8% | -35.1% | -0.3% | – | -92.6% | 0.0% | 7.5% | |
| – | – | 799.5% | – | – | 1,201.1% | 10,472.9% | 945.4% | – | 12,067.9% | 660.5% | 2,440.6% | |
| – | – | 199.4% | – | – | -3,516.5% | 9,339.4% | -3,153.8% | – | 9,636.1% | -10,706.8% | -2,863.8% | |
| – | – | -600.1% | – | – | -4,717.7% | -1,133.4% | -4,099.3% | – | -2,431.8% | -8,701.2% | -5,235.3% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.